Pharmaceutical preparation for treating disorders of the skin

Claim 1

A method for the treatment of a disorder of the skin of a human or other mammal selected from the group consisting of mycosis fungoids, basal cell carcinoma, keratosis solaris, Bowen squamous cell carcinoma, Kaposi sarcoma, leishmaniasis diffusa, adenocarcinoma and melanoma, which comprises disinfecting the affected area and adjacent areas of the skin, removing the stratum corneum by repeated applications of pressure sensitive type, applying an effective amount of ointment, consisting essentially of an amount sufficient of killed mycobacteriae BCG and cord factor (trehalose-6,6-dimycolate) to effectively treat mycosis fungoids, basal cell carcinoma, Kaposi sarcoma, leishmaniasis diffusa, adenocarcinoma and melanoma, in a vehicle suitable for topical pharmaceutical application and capable of efficiently maintaining the active ingredients at the desired location on the skin for 24 to about 48 hours, said amount sufficient of the active ingredients constituting from 1.5 mg to 75 mg per gram of said ointment of said killed mycobacteriae and from 0.07 mg to 0.15 mg of said cord factor per gram of ointment, covering same with an impervious wrap, and leaving same in place for a period of time of about 24 to 48 hours.

Claim 2

A method for the treatment of a disorder of the skin of a human or other mammal selected from the group consisting of mycosis fungoids, basal cell carcinoma, keratosis solaris, Bowen squamous cell carcinoma, Kaposi sarcoma, leishmaniasis diffusa, adenocarcinoma and melanoma, which comprises disinfecting the affected area and adjacent areas of the skin, removing the stratum corneum by repeated applications of pressure sensitive type, applying an effective amount of ointment, consisting essentially of an amount sufficient of killed mycobacteriae BCG and cord factor (trehalose-6,6-dimycolate) to effectively treat mycosis fungoids, basal cell carcinoma, Kaposi sarcoma, leishmaniasis diffusa, adenocarcinoma and melanoma, in a vehicle suitable for topical pharmaceutical application and capable of efficiently maintaining the active ingredients at the desired location on the skin for 24 to about 48 hours, said amount sufficient of the active ingredients constituting from 1.5 mg to 75 mg per gram of said ointment of said killed mycobacteriae and from 0.07 mg to 0.15 mg of said cord factor per gram of ointment, covering same with an impervious wrap, and leaving same in place for a period of time of about 24 to 48 hours.

Claim 3

A method for the treatment of a disorder of the skin of a human or other mammal selected from the group consisting of mycosis fungoids, basal cell carcinoma, keratosis solaris, Bowen squamous cell carcinoma, Kaposi sarcoma, leishmaniasis diffusa, adenocarcinoma and melanoma, which comprises disinfecting the affected area and adjacent areas of the skin, removing the stratum corneum by repeated applications of pressure sensitive tape, applying an effective amount of an ointment, consisting essentially of an amount sufficient of killed mycobacteriae BCG and cord factor (trehalose-6,6-dimycolate) to effectively treat mycosis fungoids, basal cell carcinoma, Kaposi sarcoma, leishmaniasis diffusa, adenocarcinoma and melanoma, in a vehicle suitable for topical pharmaceutical application and capable of efficiently maintaining the active ingredients at the desired location on the skin for 24 to about 48 hours, said amount sufficient of the active ingredients constituting from 1.5 mg to 15 mg per gram of said ointment of said killed mycobacteriae and from 0.07 mg to 0.15 mg of said cord factor per gram of ointment, and said inert vehicle is selected from the group consisting of petroleum jelly, organic or inorganic waxes and peanut oil, covering same with an impervious wrap, and leaving same in place for a period of time of about 24 to 48 hours.

Claim 4

A method for the treatment of a disorder of the skin of a human or other mammal selected from the group consisting of mycosis fungoids, basal cell carcinoma, keratosis solaris, Bowen squamous cell carcinoma, Kaposi sarcoma, leishmaniasis diffusa, adenocarcinoma and melanoma, which comprises disinfecting the affected area and adjacent areas of the skin, removing the stratum corneum by repeated applications of pressure sensitive tape, applying an effective amount of an ointment, consisting essentially of an amount sufficient of killed mycobacteriae BCG and cord factor (trehalose-6,6-dimycolate) to effectively treat mycosis fungoids, basal cell carcinoma, Kaposi sarcoma, leishmaniasis diffusa, adenocarcinoma and melanoma, in a vehicle suitable for topical pharmaceutical application and capable of efficiently maintaining the active ingredients at the desired location on the skin for 24 to about 48 hours, said amount sufficient of the active ingredients constituting from 1.5 mg to 15 mg per gram of said ointment of said killed mycobacteriae and from 0.07 mg to 0.15 mg of said cord factor per gram of ointment, and said inert vehicle is selected from the group consisting of petroleum jelly, organic or inorganic waxes and peanut oil, covering same with an impervious wrap, and leaving same in place for a period of time of about 24 to 48 hours.